{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T15:31:26Z","timestamp":1794065486270,"version":"4.8.0"},"reference-count":63,"publisher":"Informa UK Limited","issue":"3","license":[{"start":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T00:00:00Z","timestamp":1614124800000},"content-version":"unspecified","delay-in-days":488,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer Inc","doi-asserted-by":"publisher","award":["-"],"award-info":[{"award-number":["-"]}],"id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines & Immunotherapeutics"],"published-print":{"date-parts":[[2020,3,3]]},"DOI":"10.1080\/21645515.2019.1667206","type":"journal-article","created":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T20:00:55Z","timestamp":1572033655000},"page":"530-538","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":28,"title":["Unique product quality considerations in vaccine development, registration and new program implementation in Malaysia"],"prefix":"10.1080","volume":"16","author":[{"given":"Yvonne S. K.","family":"Khoo","sequence":"first","affiliation":[{"name":"Ministry of Health, Malaysia","place":["Petaling Jaya, Malaysia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Ab","family":"Ghani","sequence":"additional","affiliation":[{"name":"Ministry of Health, Malaysia","place":["Petaling Jaya, Malaysia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. A.","family":"Navamukundan","sequence":"additional","affiliation":[{"name":"Pfizer Inc., Medical Affairs","place":["Kuala Lumpur, Malaysia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Jahis","sequence":"additional","affiliation":[{"name":"Ministry of Health, Malaysia","place":["Putrajaya, Malaysia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gamil","sequence":"additional","affiliation":[{"name":"Emerging Markets Vaccines Medical and Scientific Affairs","place":["Dubai, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2019,10,25]]},"reference":[{"key":"e_1_3_3_2_1","volume-title":"Paper presented at: Vaccinology 2017\u2013 III International Symposium for Asia Pacific Experts","author":"Kusnin F.","year":"2017","unstructured":"Kusnin F. Immunisation programme in Malaysia. Paper presented at: Vaccinology 2017\u2013 III International Symposium for Asia Pacific Experts; 2017 Oct 16\u201319; Hanoi, Vietnam."},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2017.09.007"},{"key":"e_1_3_3_4_1","unstructured":"Arumugam T. Experts blast anti-vaccinists. New Straits Times. 2016 Jun 24 [accessed 2018 Feb 23]. https:\/\/www.nst.com.my\/news\/2016\/06\/154190\/experts-blast-anti-vaccinists."},{"key":"e_1_3_3_5_1","unstructured":"Reduan H. Anti-vaxxer cases on the rise in Pahang. New Straits Times. 2017 Apr 5 [accessed 2018 May 13]. https:\/\/www.nst.com.my\/news\/2017\/04\/227441\/anti-vaxxer-cases-rise-pahang."},{"key":"e_1_3_3_6_1","unstructured":"Putrajaya: vaccination for children will soon be mandatory. Malay Mail Online. 2015 Dec 1 [accessed 2017 Nov 22]. https:\/\/www.malaymail.com\/news\/malaysia\/2015\/12\/01\/putrajaya-vaccination-for-children-will-soon-be-mandatory\/1014775."},{"key":"e_1_3_3_7_1","unstructured":"Kamal SM. Health Ministry says anti-vaccine movement due to fears of pig DNA in drugs. Malay Mail Online. 2015 Oct 26 [accessed 2018 Feb 23]. https:\/\/www.malaymail.com\/news\/malaysia\/2015\/10\/26\/health-ministry-says-anti-vaccine-movement-due-to-fears-of-pig-dna-in-drugs\/993787."},{"key":"e_1_3_3_8_1","unstructured":"Department of Statistics Malaysia. Population distribution and basic demographic characteristics. Putrajaya. 2010 [accessed 2018 Nov 12]. https:\/\/www.dosm.gov.my\/v1\/index.php?r=column\/ctheme&menu_id=L0pheU43NWJwRWVSZklWdzQ4TlhUUT09&bul_id=MDMxdHZjWTk1SjFzTzNkRXYzcVZjdz09."},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1080\/2331205X.2016.1142410"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1177\/1010539517751312"},{"key":"e_1_3_3_11_1","first-page":"42","article-title":"Issues in vaccine hesitancy in Malaysia: a countering approach","volume":"2","author":"Wan Taib WR","year":"2017","unstructured":"Wan Taib WR, Yusoff NAM, Tengku MA, Aryati A. Issues in vaccine hesitancy in Malaysia: a countering approach. J Biomed Clin Sci. 2017;2:42\u201346.","journal-title":"J Biomed Clin Sci"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.05.007"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.6007\/IJARBSS\/v7-i12\/3642"},{"key":"e_1_3_3_14_1","unstructured":"Ministry of Health Malaysia. Incidence rate and mortality rate of communicable diseases. 2013 [accessed 2019 Aug 3]. http:\/\/www.moh.gov.my\/index.php\/pages\/view\/324?mid=283."},{"key":"e_1_3_3_15_1","first-page":"775","article-title":"Evaluation of conventional PCR for detection of toxigenic Corynebacterium diphtheriae strains in Malaysia","volume":"35","author":"Liow YL","year":"2018","unstructured":"Liow YL, Rohaidah H, Fairuz A, Hazwani H, Ain DN, Norazah A. Evaluation of conventional PCR for detection of toxigenic Corynebacterium diphtheriae strains in Malaysia. Trop Biomed. 2018;35:775\u201380.","journal-title":"Trop Biomed"},{"key":"e_1_3_3_16_1","unstructured":"United Nations Office for the Coordination of Humanitarian Affairs (OCHA). Humanitarian bulletin Pakistan issue 22 (16 December 2013\u201315 January 2014). 2014 [accessed 2018 Sept 23]. https:\/\/reliefweb.int\/sites\/reliefweb.int\/files\/resources\/humanitarian-bulletin-pakistan-january-2014_final_17%20jan.pdf."},{"key":"e_1_3_3_17_1","unstructured":"World Health Organization. Government of Nigeria reports 2 wild polio cases first since July 2014. 2016 [accessed 2018 Sept 24]. http:\/\/www.who.int\/mediacentre\/news\/releases\/2016\/nigeria-polio\/en\/."},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.1353"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aao5945"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2014.933077"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2015.964212"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.08.016"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.04.036"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.04.043"},{"key":"e_1_3_3_25_1","unstructured":"Ministry of Health Malaysia (MOH) Department of Islamic Development Malaysia (JAKIM). Frequently asked questions on vaccine and immunisation. 2015 Jul [accessed 2018 Feb 27]. http:\/\/www.moh.gov.my\/index.php\/file_manager\/dl_item\/554756755a584a69615852686269394859584a70637942515957356b645746754c31426c626d6431636e567a595734675330567a615768686447467549435967613246335957786862694277655774706443395462324673595735666247463661573166596d5679613246706447467558315a6861334e70626c394a6258567561584e6863326c664d4449774e7a49774d5455756347526d."},{"key":"e_1_3_3_26_1","unstructured":"Jabatan Kemajuan Islam Malaysia (JAKIM). Manual procedure for Malaysia halal certification (third revision). 2014 [accessed 2018 Feb 27]. www.halal.gov.my\/v4\/images\/pdf\/MPPHM2014BI.pdf."},{"key":"e_1_3_3_27_1","unstructured":"Department of Standards Malaysia (STANDARDS MALAYSIA). MS 2424:2012 Halal pharmaceuticals \u2013 general guidelines. 2012 [accessed 2018 Feb 27]. https:\/\/law.resource.org\/pub\/my\/ibr\/ms.2424.2012.pdf."},{"key":"e_1_3_3_28_1","volume-title":"Vaccine fact book","author":"Plotkin SA","year":"2012","unstructured":"Plotkin SA. Vaccine fact book. 2012 [accessed 2018 Feb 27]. http:\/\/www.phrma-jp.org\/wordpress\/wp-content\/uploads\/old\/library\/vaccine-factbook_e\/vaccine_factbook_2012_en.pdf."},{"key":"e_1_3_3_29_1","unstructured":"Vaccines Europe. How are vaccines produced? [accessed 2018 Mar 29]. https:\/\/www.vaccineseurope.eu\/about-vaccines\/key-facts-on-vaccines\/how-are-vaccines-produced\/."},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/bit.24493"},{"key":"e_1_3_3_31_1","unstructured":"European Medicines Agency. Guideline on the use of porcine trypsin used in the manufacture of human biological medicinal products. 2013 [accessed 2018 Mar 2]. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2013\/03\/WC500139532.pdf."},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.02.026"},{"key":"e_1_3_3_33_1","unstructured":"Centers for Disease Control and Prevention. Vaccine excipient & media summary. Excipients included in U.S. vaccines by vaccine. 2018 [accessed 2018 March 29]. https:\/\/www.cdc.gov\/vaccines\/pubs\/pinkbook\/downloads\/appendices\/b\/excipient-table-2.pdf."},{"key":"e_1_3_3_34_1","unstructured":"MIMS Malaysia. Varivax full prescribing info. [accessed 2018 Mar 29]. https:\/\/www.mims.com\/malaysia\/drug\/info\/varivax\/?type=full."},{"key":"e_1_3_3_35_1","unstructured":"MIMS Malaysia. MMR II full prescribing info. [accessed 2018 Mar 29]. https:\/\/www.mims.com\/malaysia\/drug\/info\/m-m-r%20ii\/?type=full."},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-018-0956-0"},{"key":"e_1_3_3_37_1","unstructured":"World Health Organization Regional Office for the Eastern Mediterranean (EMRO). Oral polio vaccine and its production. [accessed 2018 July 13]. http:\/\/www.emro.who.int\/polio\/information-resources\/oral-polio-vaccine-production.html."},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/291503a0"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1590\/s0100-879x2012007500142"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1387-2656(07)13004-0"},{"key":"e_1_3_3_41_1","unstructured":"Sanofi. Sanofi Pasteur statement on the discontinuation of meningococcal polysaccharide vaccine groups A C Y and W-135 combined. 2017 [accessed 2018 May 4]. http:\/\/www.news.sanofi.us\/Sanofi-Pasteur-Statement-on-the-Discontinuation-of-Meningococcal-Polysaccharide-Vaccine-Groups-A-C-Y-and-W-135-Combined."},{"key":"e_1_3_3_42_1","unstructured":"DagangHalal.com. JAKIM: Malaysia\u2019s sole halal certification body. [accessed 2017 Nov 23]. http:\/\/www.daganghalal.com\/HalalInfo\/HalalArticlesDtl.aspx?id=206."},{"key":"e_1_3_3_43_1","unstructured":"National Pharmaceutical Regulatory Division Ministry of Health Malaysia. Drug registration guidance document (second edition). 2018 [accessed 2018 May 26]. http:\/\/npra.moh.gov.my\/index.php\/guidelines-central."},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1080\/10454446.2014.921869"},{"key":"e_1_3_3_45_1","first-page":"1","volume-title":"Proceedings of the European and Mediterranean Conference on Information Systems, EMCIS 2009","author":"Noordin N","year":"2009","unstructured":"Noordin N, Md Noor NL, Hashim M, Samicho Z. Value chain of halal certification system: a case of the Malaysia halal industry. In: Proceedings of the European and Mediterranean Conference on Information Systems, EMCIS 2009; 2009 Jul 13-14; Izmir, Turkey. p. 1\u201314."},{"key":"e_1_3_3_46_1","unstructured":"Jabatan Kemajuan Islam Malaysia (JAKIM). The recognised foreign halal certification bodies & authorities. 2017 Sept 15 [accessed 2018 Aug 1]. http:\/\/www.halal.gov.my\/ckfinder\/userfiles\/files\/cb\/CB%20List%20LATEST%20.pdf."},{"key":"e_1_3_3_47_1","unstructured":"Islamic Food and Nutrition Council of America (IFANCA). Frequently asked questions. [accessed 2017 Nov 14]. http:\/\/www.ifanca.org\/Pages\/Index.aspx."},{"key":"e_1_3_3_48_1","unstructured":"Halal Food Council of Europe (HFCE). Frequently asked questions. 2017 [accessed 2017 Nov 23]. http:\/\/www.hfce.eu\/index.html."},{"key":"e_1_3_3_49_1","unstructured":"Institute for Vaccine Safety Johns Hopkins Bloomberg School of Public Health. Religious leaders approval of use of vaccines containing porcine gelatine. 2003 [accessed 2017 Nov 23]. http:\/\/www.vaccinesafety.edu\/Porcine-vaccineapproval.htm."},{"key":"e_1_3_3_50_1","unstructured":"World Health Organization. Guidelines for the pharmacovigilance on safety of vaccines in Malaysia. 2017 [accessed 2018 Jul 15]. http:\/\/apps.who.int\/medicinedocs\/documents\/s18592en\/s18592en.pdf."},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006904"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.04.010"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1136\/adc.87.1.22"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.7.2.e17"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1108\/17590831311329304"},{"key":"e_1_3_3_56_1","unstructured":"Liu P. BioWorld. Annual Hajj points to untapped growing halal vaccines market. 2016 [accessed 2017 Nov 14]. http:\/\/www.bioworld.com\/content\/annual-hajj-points-untapped-growing-halal-vaccines-market-1."},{"key":"e_1_3_3_57_1","unstructured":"The OIC program on achieving Self Reliance in Vaccine Production (SRVP) in the Islamic world. 2016 [accessed 2017 Nov 21]. http:\/\/www.isdb.org\/irj\/go\/km\/docs\/documents\/IDBDevelopments\/Internet\/English\/IDB\/CM\/Cooperation\/Science%20&%20Technology\/Projects\/Vaccine%20Production\/AboutSRVP.html."},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.12816\/0009873"},{"key":"e_1_3_3_59_1","unstructured":"Euronews. Halal vaccines \u201cto be ready in three years\u201d. 2014 [accessed 2017 Nov 14]. http:\/\/www.euronews.com\/2014\/04\/10\/halal-vaccines-to-be-ready-in-three-years-."},{"key":"e_1_3_3_60_1","unstructured":"SalaamGateway. Case study-AJ Pharma developing the world\u2019s first halal vaccines. 2016 [accessed 2017 Nov 14]. https:\/\/www.salaamgateway.com\/en\/story\/case_studyaj_pharma_developing_the_worlds_first_halal_vaccines-salaam15112016071225\/."},{"key":"e_1_3_3_61_1","unstructured":"Halal Focus. Malaysia: world\u2019s first halal vaccine plant to begin production in early 2018. 2015 [accessed 2017 Nov 22]. http:\/\/halalfocus.net\/malaysia-worlds-first-halal-vaccine-plant-to-begin-production-in-early-2018\/."},{"key":"e_1_3_3_62_1","unstructured":"European Medicines Agency. Guideline on clinical evaluation of new vaccines. 2006 [accessed 2019 Aug 7]. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-clinical-evaluation-new-vaccines_en.pdf."},{"key":"e_1_3_3_63_1","unstructured":"Food and Drug Administration. Guidance for industry: general principles for the development of vaccines to protect against global infectious disease. 2011 [accessed 2019 Aug 7]. https:\/\/www.fda.gov\/media\/82306\/download."},{"key":"e_1_3_3_64_1","unstructured":"World Health Organization. Annex 2: guidelines for independent lot release of vaccines by regulatory authorities. 2013 [accessed 2019 Aug 7]. http:\/\/apps.who.int\/medicinedocs\/documents\/s21098en\/s21098en.pdf."}],"container-title":["Human Vaccines & Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2019.1667206","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T15:08:57Z","timestamp":1748963337000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2019.1667206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,25]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3,3]]}},"alternative-id":["10.1080\/21645515.2019.1667206"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2019.1667206","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,25]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2019-06-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-08-22","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-09-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}